{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:12:16Z","timestamp":1785841936863,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010018","name":"Doctoral Start-up Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2021-BS-209"],"award-info":[{"award-number":["2021-BS-209"]}],"id":[{"id":"10.13039\/501100010018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Renal clear cell carcinoma (RCC) is a common cancer in urinary system with increasing incidence. At present, targeted therapy and immunotherapy are the main therapeutic programs in clinical therapy. To develop novel drugs and provide new ideas for clinical therapy, the identification of potential ccRCC subtypes and potential target genes or pathways has become a current research focus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>The aim of this study was to explore the underlying mechanisms of mitochondrial function in ccRCC. This regulatory pathway is closely related to tumor development and metastasis in ccRCC patients, and their abnormal changes may affect the prognosis of cancer patients. Therefore, we decided to construct a prognostic model of ccRCC patients based on mitochondrial regulatory genes, aiming to provide new methods and ideas for clinical therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>The 5-year survival prediction model based on iterative LASSO reached 0.746, and the cox model based on coxph reached C-index\u2009=\u20090.77, integrated c\/D AUC\u2009=\u20090.61, and integrated brier score\u2009=\u20090.14. The rsf model based on randomForestSRC was built with C-index\u2009=\u20090.82, integrated c\/D AUC\u2009=\u20090.69, and integrated brier score\u2009=\u20090.11. The results show that mitochondrial regulatory pathway is a potential target pathway for clinical therapy of ccRCC, which can provide guidelines for clinical targeted therapy, immunotherapy and other first-line therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-023-05393-8","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T17:01:42Z","timestamp":1695661302000},"page":"17015-17026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Potential value of mitochondrial regulatory pathways in the clinical application of clear cell renal cell carcinoma: a machine learning-based study"],"prefix":"10.1007","volume":"149","author":[{"given":"Xiaochen","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"5393_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/cells8070680","volume":"8","author":"SJ Annesley","year":"2019","unstructured":"Annesley SJ, Fisher PR (2019) Mitochondria in health and disease. Cells 8:680. https:\/\/doi.org\/10.3390\/cells8070680","journal-title":"Cells"},{"key":"5393_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18:220. https:\/\/doi.org\/10.1186\/s13059-017-1349-1","journal-title":"Genome Biol"},{"key":"5393_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli I, Gareau Y, Lehnertz B et al (2019) Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell 36:84-99.e8. https:\/\/doi.org\/10.1016\/j.ccell.2019.06.003","journal-title":"Cancer Cell"},{"key":"5393_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17:218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5","journal-title":"Genome Biol"},{"key":"5393_CR5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","volume":"26","author":"DA Braun","year":"2020","unstructured":"Braun DA, Hou Y, Bakouny Z et al (2020) Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med 26:909\u2013918. https:\/\/doi.org\/10.1038\/s41591-020-0839-y","journal-title":"Nat Med"},{"key":"5393_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/CBM-2011-0176","volume":"9","author":"P Cairns","year":"2010","unstructured":"Cairns P (2010) Renal cell carcinoma. Cancer Biomark 9:461\u2013473. https:\/\/doi.org\/10.3233\/CBM-2011-0176","journal-title":"Cancer Biomark"},{"key":"5393_CR7","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbrc.2019.06.127","volume":"516","author":"Z Chen","year":"2019","unstructured":"Chen Z, Yang H, Li Z et al (2019) Temsirolimus as a dual inhibitor of retinoblastoma and angiogenesis via targeting mTOR signalling. Biochem Biophys Res Commun 516:726\u2013732. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.127","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 1","key":"5393_CR8","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/onc.2009.40","volume":"27","author":"G Chinnadurai","year":"2008","unstructured":"Chinnadurai G, Vijayalingam S, Rashmi R (2008) BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 27(Suppl 1):S20-29. https:\/\/doi.org\/10.1038\/onc.2009.40","journal-title":"Oncogene"},{"key":"5393_CR9","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMra043172","volume":"353","author":"HT Cohen","year":"2005","unstructured":"Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353:2477\u20132490. https:\/\/doi.org\/10.1056\/NEJMra043172","journal-title":"N Engl J Med"},{"key":"5393_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C et al (2016) TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44:e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507","journal-title":"Nucleic Acids Res"},{"key":"5393_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40134-013-0016-x","volume":"1","author":"J Czernin","year":"2013","unstructured":"Czernin J, Allen-Auerbach M, Nathanson D, Herrmann K (2013) PET\/CT in oncology: current status and perspectives. Curr Radiol Rep 1:177\u2013190. https:\/\/doi.org\/10.1007\/s40134-013-0016-x","journal-title":"Curr Radiol Rep"},{"key":"5393_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jconrel.2022.01.051","volume":"343","author":"J Du","year":"2022","unstructured":"Du J, Wang C, Chen Y et al (2022) Targeted downregulation of HIF-1\u03b1 for restraining circulating tumor microemboli mediated metastasis. J Control Release 343:457\u2013468. https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.051","journal-title":"J Control Release"},{"key":"5393_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41419-023-05599-1","volume":"14","author":"R Fad\u00f3","year":"2023","unstructured":"Fad\u00f3 R, Zagmutt S, Herrero L et al (2023) To be or not to be a fat burner, that is the question for cpt1c in cancer cells. Cell Death Dis 14:57. https:\/\/doi.org\/10.1038\/s41419-023-05599-1","journal-title":"Cell Death Dis"},{"key":"5393_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C et al (2019) Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med 11:34. https:\/\/doi.org\/10.1186\/s13073-019-0638-6","journal-title":"Genome Med"},{"key":"5393_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, Guigas B, Bertrand L et al (2014) Metformin: from mechanisms of action to therapies. Cell Metab 20:953\u2013966. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.018","journal-title":"Cell Metab"},{"key":"5393_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS (2014) pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE 9:e107468. https:\/\/doi.org\/10.1371\/journal.pone.0107468","journal-title":"PLoS ONE"},{"key":"5393_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER (2015) VHL, the story of a tumour suppressor gene. Nat Rev Cancer 15:55\u201364. https:\/\/doi.org\/10.1038\/nrc3844","journal-title":"Nat Rev Cancer"},{"key":"5393_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4343","volume":"23","author":"S Harlander","year":"2017","unstructured":"Harlander S, Sch\u00f6nenberger D, Toussaint NC et al (2017) Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice. Nat Med 23:869\u2013877. https:\/\/doi.org\/10.1038\/nm.4343","journal-title":"Nat Med"},{"key":"5393_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139933","volume":"131","author":"K Heishima","year":"2021","unstructured":"Heishima K, Sugito N, Soga T et al (2021) Petasin potently inhibits mitochondrial complex I-based metabolism that supports tumor growth and metastasis. J Clin Invest 131:e139933. https:\/\/doi.org\/10.1172\/JCI139933","journal-title":"J Clin Invest"},{"key":"5393_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Walker CL, Rathmell WK (2021) Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol 17:245\u2013261. https:\/\/doi.org\/10.1038\/s41581-020-00359-2","journal-title":"Nat Rev Nephrol"},{"key":"5393_CR21","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M et al (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353\u2013D361. https:\/\/doi.org\/10.1093\/nar\/gkw1092","journal-title":"Nucleic Acids Res"},{"key":"5393_CR22","doi-asserted-by":"publisher","first-page":"573326","DOI":"10.3389\/fimmu.2020.573326","volume":"11","author":"K Klein","year":"2020","unstructured":"Klein K, He K, Younes AI et al (2020) Role of mitochondria in cancer immune evasion and potential therapeutic approaches. Front Immunol 11:573326. https:\/\/doi.org\/10.3389\/fimmu.2020.573326","journal-title":"Front Immunol"},{"key":"5393_CR23","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41375-020-0949-z","volume":"34","author":"M Konopleva","year":"2020","unstructured":"Konopleva M, Martinelli G, Daver N et al (2020) MDM2 inhibition: an important step forward in cancer therapy. Leukemia 34:2858\u20132874. https:\/\/doi.org\/10.1038\/s41375-020-0949-z","journal-title":"Leukemia"},{"key":"5393_CR24","doi-asserted-by":"publisher","first-page":"100670","DOI":"10.1016\/j.drup.2019.100670","volume":"49","author":"J Kopecka","year":"2020","unstructured":"Kopecka J, Trouillas P, Ga\u0161parovi\u0107 A\u010c et al (2020) Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets. Drug Resist Updat 49:100670. https:\/\/doi.org\/10.1016\/j.drup.2019.100670","journal-title":"Drug Resist Updat"},{"key":"5393_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell 13:472\u2013482. https:\/\/doi.org\/10.1016\/j.ccr.2008.05.005","journal-title":"Cancer Cell"},{"key":"5393_CR26","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/jcp.29969","volume":"236","author":"Y Lai","year":"2021","unstructured":"Lai Y, Tang F, Huang Y et al (2021) The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy. J Cell Physiol 236:1616\u20131627. https:\/\/doi.org\/10.1002\/jcp.29969","journal-title":"J Cell Physiol"},{"key":"5393_CR27","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B et al (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77:e108\u2013e110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307","journal-title":"Cancer Res"},{"key":"5393_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41586-020-2993-2","volume":"589","author":"C Lorenzo","year":"2021","unstructured":"Lorenzo C, Delgado P, Busse CE et al (2021) ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies. Nature 589:287\u2013292. https:\/\/doi.org\/10.1038\/s41586-020-2993-2","journal-title":"Nature"},{"key":"5393_CR29","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu X, Meng J, Zhou Y et al (2021) MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics 36:5539\u20135541. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018","journal-title":"Bioinformatics"},{"key":"5393_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.diabres.2018.05.023","volume":"143","author":"R Mallik","year":"2018","unstructured":"Mallik R, Chowdhury TA (2018) Metformin in cancer. Diabetes Res Clin Pract 143:409\u2013419. https:\/\/doi.org\/10.1016\/j.diabres.2018.05.023","journal-title":"Diabetes Res Clin Pract"},{"key":"5393_CR31","doi-asserted-by":"publisher","first-page":"102943","DOI":"10.1016\/j.ebiom.2020.102943","volume":"59","author":"S Missiroli","year":"2020","unstructured":"Missiroli S, Perrone M, Genovese I et al (2020) Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours. EBioMedicine 59:102943. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102943","journal-title":"EBioMedicine"},{"key":"5393_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"key":"5393_CR33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148:1145\u20131159. https:\/\/doi.org\/10.1016\/j.cell.2012.02.035","journal-title":"Cell"},{"key":"5393_CR34","doi-asserted-by":"publisher","first-page":"918647","DOI":"10.3389\/fphar.2022.918647","volume":"13","author":"X Qi","year":"2022","unstructured":"Qi X, Che X, Li Q et al (2022) Potential application of pyroptosis in kidney renal clear cell carcinoma immunotherapy and targeted therapy. Front Pharmacol 13:918647. https:\/\/doi.org\/10.3389\/fphar.2022.918647","journal-title":"Front Pharmacol"},{"key":"5393_CR35","doi-asserted-by":"publisher","first-page":"174397","DOI":"10.1016\/j.ejphar.2021.174397","volume":"909","author":"J Quan","year":"2021","unstructured":"Quan J, Bode AM, Luo X (2021) ACSL family: The regulatory mechanisms and therapeutic implications in cancer. Eur J Pharmacol 909:174397. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174397","journal-title":"Eur J Pharmacol"},{"key":"5393_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","volume":"2120","author":"J Racle","year":"2020","unstructured":"Racle J, Gfeller D (2020) EPIC: a tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol Biol 2120:233\u2013248. https:\/\/doi.org\/10.1007\/978-1-0716-0327-7_17","journal-title":"Methods Mol Biol"},{"key":"5393_CR37","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S, Sharma R, Gupta R et al (2021) MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res 49:D1541\u2013D1547. https:\/\/doi.org\/10.1093\/nar\/gkaa1011","journal-title":"Nucleic Acids Res"},{"key":"5393_CR38","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1158\/1078-0432.CCR-21-0715","volume":"27","author":"MN Saleh","year":"2021","unstructured":"Saleh MN, Patel MR, Bauer TM et al (2021) Phase 1 trial of ALRN-6924, a dual inhibitor of MDMX and MDM2, in patients with solid tumors and lymphomas bearing wild-type TP53. Clin Cancer Res 27:5236\u20135247. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-0715","journal-title":"Clin Cancer Res"},{"key":"5393_CR39","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"5393_CR40","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1158\/1078-0432.CCR-11-3302","volume":"18","author":"A Sveen","year":"2012","unstructured":"Sveen A, \u00c5gesen TH, Nesbakken A et al (2012) ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. Clin Cancer Res 18:6001\u20136010. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-3302","journal-title":"Clin Cancer Res"},{"key":"5393_CR41","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1097\/JTO.0b013e318233d835","volume":"6","author":"JMG Taylor","year":"2011","unstructured":"Taylor JMG (2011) Random survival forests. J Thorac Oncol 6:1974\u20131975. https:\/\/doi.org\/10.1097\/JTO.0b013e318233d835","journal-title":"J Thorac Oncol"},{"key":"5393_CR42","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"The Gene Ontology Consortium","year":"2019","unstructured":"The Gene Ontology Consortium (2019) The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res 47:D330\u2013D338. https:\/\/doi.org\/10.1093\/nar\/gky1055","journal-title":"Nucleic Acids Res"},{"key":"5393_CR43","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-17-1076","volume":"17","author":"JM Thompson","year":"2018","unstructured":"Thompson JM, Alvarez A, Singha MK et al (2018) Targeting the mevalonate pathway suppresses VHL-deficient CC-RCC through a HIF-dependent mechanism. Mol Cancer Ther 17:1781\u20131792. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-1076","journal-title":"Mol Cancer Ther"},{"key":"5393_CR44","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M (2015) The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (pozn) 19:A68-77. https:\/\/doi.org\/10.5114\/wo.2014.47136","journal-title":"Contemp Oncol (pozn)"},{"key":"5393_CR45","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B et al (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529","journal-title":"Science"},{"key":"5393_CR46","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A (2019) The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol 95:912\u2013919. https:\/\/doi.org\/10.1080\/09553002.2019.1589653","journal-title":"Int J Radiat Biol"},{"key":"5393_CR47","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12:685\u2013698. https:\/\/doi.org\/10.1038\/nrc3365","journal-title":"Nat Rev Cancer"},{"key":"5393_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrneph.2017.59","volume":"13","author":"HI Wettersten","year":"2017","unstructured":"Wettersten HI, Aboud OA, Lara PN, Weiss RH (2017) Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol 13:410\u2013419. https:\/\/doi.org\/10.1038\/nrneph.2017.59","journal-title":"Nat Rev Nephrol"},{"key":"5393_CR49","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2012","unstructured":"Yang W, Soares J, Greninger P et al (2012) Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41:D955\u2013D961. https:\/\/doi.org\/10.1093\/nar\/gks1111","journal-title":"Nucleic Acids Res"},{"key":"5393_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/nu9111176","author":"M-S Yoon","year":"2017","unstructured":"Yoon M-S (2017) The role of mammalian target of rapamycin (mTOR) in insulin signaling. Nutrients. https:\/\/doi.org\/10.3390\/nu9111176","journal-title":"Nutrients"},{"key":"5393_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6010035","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zhang Q (2018) VHL and hypoxia signaling: beyond HIF in CANCER. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines6010035","journal-title":"Biomedicines"},{"key":"5393_CR52","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1038\/ncomms3935","volume":"4","author":"C Zhang","year":"2013","unstructured":"Zhang C, Liu J, Liang Y et al (2013) Tumour-associated mutant p53 drives the Warburg effect. Nat Commun 4:2935. https:\/\/doi.org\/10.1038\/ncomms3935","journal-title":"Nat Commun"},{"key":"5393_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82206","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang J, Riquelme MA, Hua R et al (2022) Connexin 43 hemichannels regulate mitochondrial ATP generation, mobilization, and mitochondrial homeostasis against oxidative stress. Elife 11:e82206. https:\/\/doi.org\/10.7554\/eLife.82206","journal-title":"Elife"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05393-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05393-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:02:28Z","timestamp":1700344948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05393-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":53,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5393"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05393-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong University. Each participant signed an informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}